Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1312 of 5804
-
Mindfulness over meds? new study tests stress reduction for black Women's heart health
Symptom relief Recruiting nowHigh blood pressure is a powerful risk factor for heart disease. Black women are more likely to have high blood pressure than white women or Hispanic women. Even when they are aware they have high blood pressure, many people struggle to keep their blood pressure controlled. Resea…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New combo therapy aims to keep lung cancer from returning after surgery
Disease control OngoingThe objective of this study is to explore the safety of alectinib in combination with chemotherapy in participants with resectable NSCLC. Cohort B1 is a phase II cohort that will assess the safety of alectinib in combination with up to four cycles of platinum-based chemotherapy i…
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could albumin boost oxygen delivery in sepsis? new trial investigates
Disease control CompletedFluid resuscitation is a critical component of sepsis treatment. Research has shown that intravenous (IV) fluid therapy in sepsis positively impacts cardiac output and thereby oxygen (O2) delivery through a complex interaction of central venous pressure, right atrial pressure, ve…
Sponsor: Samsun University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
VR headset vs. pills: which beats social anxiety in teens?
Symptom relief Recruiting nowThis study compares two treatment approaches for adolescents and young adults with social anxiety. One group will participate in therapy sessions using a virtual reality headset, while the other group will receive sertraline, a commonly used medication for social anxiety. The goa…
Phase: PHASE4 • Sponsor: Emine Kanmaz • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Blood test could spot lung transplant trouble early
Diagnosis Recruiting nowLTx has the shortest survival of all solid organ transplants. The complex and time-demanding diagnostics of allograft dysfunction are a significant reason for this. The current study aims overarchingly to improve survival after lung transplantation (LTx) through precise and fast…
Sponsor: Jesper Magnusson • Aim: Diagnosis
Last updated Jun 26, 2026 17:35 UTC
-
Brain training shows promise for borderline personality disorder
Symptom relief Recruiting nowPrevious work by the group convinced the researchers to pursue development of focused cognitive reappraisal training as a novel approach to treatment of BPD, either as stand-alone treatment or in concert with evidence-based treatments of BPD. The present proposal aims to refine a…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Could fewer injections control wet AMD? new study tests faricimab's staying power
Disease control CompletedNeovascular Age-Related Macular Degeneration (nAMD) is a one of the leading causes of irreversible vision loss among the elderly in developed countries. The implementation of anti-VEGF therapies in the last decades has significantly improved AMD management. Faricimab (Vabysmo®), …
Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental CAR-T therapy takes on lupus and other autoimmune diseases
Disease control Recruiting nowAutoimmune diseases such as systemic lupus erythematosus (SLE), diffuse cutaneous systemic sclerosis (dcSSc), antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (AAV), idiopathic inflammatory myopathy (IIM), and Sjogren's syndrome (SS) have complex etiologies and a…
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New stem cell approach aims to treat tough anemia cases
Disease control Recruiting nowThis phase I trial evaluates the safety and feasibility of using a reduced-intensity regimen of cyclophosphamide, pentostatin, and anti-thymocyte globulin prior to a CD4+ T-cell depleted haploidentical hematopoietic cell transplant (haploHCT) for the treatment of patients with se…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can Smoke-Free homes prevent cancer in tribal communities?
Prevention Recruiting nowThis clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention …
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Spinal cord stimulator put to the test against sham for post-surgery leg pain
Symptom relief Recruiting nowObjective: To evaluate if spinal cord stimulation (SCS) performs better than placebo (no stimulation) in the long term to reduce persistent neuropathic leg pain refractory to medication and other conservative treatments in patients who have undergone lumbar spinal surgery. Study…
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Could less radiation be better for head and neck cancer?
Disease control Recruiting nowTo determine the risk of solitary elective volume recurrence following involved nodal radiotherapy (INRT) versus elective nodal irradiation (ENI)
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Last hope: experimental drug tested in single child with rare brain disease
Disease control OngoingCree Leukoencephalopathy (CLE) is a rare and fatal neurodegenerative disorder predominantly affecting the Cree population in Northern Quebec. Characterized by progressive white matter degeneration, this condition leads to severe neurological impairment and decline, leading to pre…
Phase: EARLY_PHASE1 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can cannabis ease diabetic nerve pain? new trial seeks answers
Symptom relief CompletedThe primary purpose of this study is to evaluate the safety and efficacy of medical cannabis aerosol containing 0.25, 0.50, 1.0 milligrams (mg) delta (Δ) 9-tetrahydrocannabinol (THC) inhaled three times a day (TID) compared to placebo via the Fixed-dose Syqe Inhaler on pain inten…
Phase: PHASE2 • Sponsor: Syqe Medical • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Which antibiotic wins against MRSA in the blood? new trial aims to find out
Disease control Recruiting nowThis is an open label randomized controlled trial for patients with methicillin resistant S. aureus (MRSA) bloodstream infection which will directly compare the two most commonly used therapies, vancomycin and daptomycin. This study is an approved sub-study of The Staphylococcus…
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New pill aims to silence hepatitis b virus in patients with stubborn Low-Level infection
Disease control CompletedThis study is a phase II multicenter, randomized, double-blind, placebo controlled study designed to evaluate the efficacy and safety in LLV subjects and demonstrate that TQA3605 tablets combined with oral NAs drugs can improve the efficacy and safety of LLV subjects compared wit…
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
AI could help spot dengue without expensive lab tests
Knowledge-focused CompletedDengue is a rapidly emerging infectious disease in South and Southeast Asia. Definitive diagnosis requires laboratory testing (PCR or antigen testing) which are often unavailable in settings with highest incidence. Correctly identifying patients who have dengue, and the small num…
Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New radiation technique could boost immunotherapy in advanced lung cancer
Disease control Recruiting nowThis phase II trial tests the safety and effectiveness of the combination of grid radiation therapy and standard of care (SOC) immunotherapy in treating patients with stage IV non-small lung cancer (NSCLC). Conventional radiation therapy treatments typically deliver the same radi…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for kids with rare Muscle-Weakening disease
Disease control Recruiting nowThe primary objective of this study is to assess the pharmacokinetics and pharmacodynamics of gefurulimab in pediatric participants with AChR+ gMG for the duration of the study.
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Experimental POTS drug targets racing heart in first human test
Symptom relief CompletedThis study is researching an experimental drug called REGN7544 (called "study drug"). The study is focused on participants with POTS. The aim of the study is to see how safe, tolerable, and effective the study drug is. The study is looking at several other research questions, i…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC